SHIRE HUMAN GENETIC THERAPIES, INC.
Patent Owner
Stats
- 66 US PATENTS IN FORCE
- 18 US APPLICATIONS PENDING
- Mar 15, 2018 most recent publication
Details
- 66 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,903 Total Citation Count
- Apr 20, 1994 Earliest Filing
- 44 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2018/0071,212 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF ARYLSULFATASE AAug 23, 17Mar 15, 18[A61K]
2018/0036,386 METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIAJul 12, 17Feb 08, 18[A61K]
2017/0267,986 GENERATION OF MANNOSE-6-PHOSPHATE CONTAINING RECOMBINANT ALPHA-N-ACETYL GLUCOSAMINIDASEJun 25, 15Sep 21, 17[A61K, C12N]
2017/0232,076 MANNOSE-6-PHOSPHATE BEARING PEPTIDES FUSED TO LYSOSOMAL ENZYMESAug 11, 15Aug 17, 17[A61K, C12N, C07K]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9814764 Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseMay 10, 13Nov 14, 17[A61K, C12N, C07K]
9694057 Stabilized compositions of proteins having a free thiol moietyJun 18, 15Jul 04, 17[A61K, C12N, B65B]
9682129 Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfataseDec 21, 12Jun 20, 17[A61K, C12N]
9623090 Compositions and methods for treating type III gaucher diseaseMar 01, 13Apr 18, 17[A61K, G01N]
9597376 Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisAug 19, 15Mar 21, 17[A61K]
9567585 Antisense oligonucleotide modulators of serotonin receptor 2C and uses thereofNov 09, 12Feb 14, 17[C12N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0202,929 LIPOPROTEIN LIPASE FOR TREATMENT OF HYPERTRIGLYCERIDEMIC-RELATED CONDITIONS INCLUDING ACUTE PANCREATITISAbandonedJan 20, 17Jul 20, 17[A61K, C12N]
2017/0004,827 Data Collection and Reporting System and MethodAbandonedJun 30, 15Jan 05, 17[G10L, G06F]
2016/0030,416 METHODS OF TREATING B2-BRADYKININ RECEPTOR MEDIATED ANGIOEDEMAAbandonedMar 12, 14Feb 04, 16[A61K]
2015/0313,971 METHODS AND COMPOSITIONS FOR INTRATHECALLY ADMINISTERED TREATMENT OF MUCUPOLYSACCHARIDOSIS TYPE IIIAAbandonedDec 06, 13Nov 05, 15[A61K]
2014/0057,296 ASSAYS FOR ANTIBODIES WHICH BIND TO THERAPEUTIC AGENTSAbandonedMar 01, 12Feb 27, 14[G01N]
2014/0037,612 SUBCUTANEOUS ADMINISTRATION OF ALPHA-GALACTOSIDASE AAbandonedMay 24, 13Feb 06, 14[A61K]
2014/0004,097 METHOD OF PRODUCING RECOMBINANT IDURONATE-2-SULFATASEAbandonedMar 14, 13Jan 02, 14[C12N]
2013/0337,482 ASSAYS AND KITS TO DETERMINE GALACTOCEREBROSIDASE ACTIVITY ON SOLID SUPPORTAbandonedOct 28, 11Dec 19, 13[C12Q]
2013/0295,071 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASEAbandonedApr 12, 13Nov 07, 13[A61K]
2013/0121,984 BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOFAbandonedNov 07, 12May 16, 13[A61K, C12Q]
2013/0028,881 DIAGNOSIS AND TREATMENT OF MULTIPLE SULFATASE DEFICIENCY AND OTHER SULFATASE DEFICIENCIESAbandonedJun 20, 12Jan 31, 13[A61K, C12P, C12N, A61P]
2011/0318,324 METHODS AND COMPOSITIONS FOR CNS DELIVERY OF B-GALACTOCEREBROSIDASEAbandonedJun 25, 11Dec 29, 11[A61K, A61P]
2011/0318,327 TREATMENT OF SANFILIPPO SYNDROME TYPE BAbandonedJun 25, 11Dec 29, 11[A61K, C12N, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.